Smith+Nephew, established in 1856, is a distinguished player in the global medical technology industry. With its headquarters in the United Kingdom, the company operates within key sectors such as Biotechnology, Health Care, and Medical Devices. The company's slogan, "We design and manufacture technology that takes the limits off living," underscores its commitment to enhancing patient mobility and enabling healthcare professionals to deliver optimal care.
Noted for its culture of Care, Collaboration and Courage, Smith+Nephew emphasizes innovation while fostering a supportive work environment. The firm's dedication to improving lives is encapsulated in its mission of Life Unlimited. Despite its long history, it remains dynamic with a focus on innovative technologies, although specific investment details including the last investment and investors are currently unavailable.
For potential investors, Smith+Nephew represents a robust, values-driven enterprise with longstanding market presence and substantial growth potential in the medical technology domain.